Cabotegravir
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11751 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 79 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | rheumatoid arthritis | KG + DL |
| 2 | sclerosing cholangitis | KG + DL |
| 3 | bronchitis | KG + DL |
| 4 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 5 | severe nonproliferative diabetic retinopathy | KG + DL |
| 6 | brachydactyly-syndactyly syndrome | KG + DL |
| 7 | diabetic retinopathy | KG + DL |
| 8 | non-syndromic visceral malformation | KG + DL |
| 9 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 10 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 11 | biliary atresia intrahepatic | KG + DL |
| 12 | cholestasis | KG + DL |
| 13 | colonic neoplasm | KG + DL |
| 14 | Mirizzi syndrome | KG + DL |
| 15 | diabetic nephropathy | KG + DL |
| 16 | rectosigmoid junction neoplasm | KG + DL |
| 17 | lipoma of colon | KG + DL |
| 18 | colonic lymphangioma | KG + DL |
| 19 | colon leiomyoma | KG + DL |
| 20 | cavernous hemangioma of colon | KG + DL |
| 21 | bronchial neoplasm (disease) | KG + DL |
| 22 | cecum neuroendocrine tumor G1 | KG + DL |
| 23 | cecum villous adenoma | KG + DL |
| 24 | cecal disease | KG + DL |
| 25 | benign neoplasm of cecum | KG + DL |
| 26 | benign recurrent intrahepatic cholestasis | KG + DL |
| 27 | pneumonia | KG + DL |
| 28 | laryngotracheitis | KG + DL |
| 29 | heparin cofactor 2 deficiency | KG + DL |
| 30 | antithrombin deficiency type 2 | KG + DL |
| 31 | nevus of Ito | KG + DL |
| 32 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 33 | microvillus inclusion disease | KG + DL |
| 34 | mitochondrial DNA depletion syndrome, hepatocerebral form | KG + DL |
| 35 | drug-induced liver injury | KG + DL |
| 36 | gout | KG + DL |
| 37 | pyruvate kinase deficiency of red cells | KG + DL |
| 38 | pyelonephritis | KG + DL |
| 39 | hemoglobinopathy | KG + DL |
| 40 | thrombophilia | KG + DL |
| 41 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 42 | beta-thalassemia with other manifestations | KG + DL |
| 43 | adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency | KG + DL |
| 44 | hereditary North American Indian childhood cirrhosis | KG + DL |
| 45 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 46 | familial intrahepatic cholestasis | KG + DL |
| 47 | hyperbiliverdinemia | KG + DL |
| 48 | pyropoikilocytosis, hereditary | KG + DL |
| 49 | HIV infectious disease | KG + DL |
| 50 | thrombotic disease | KG + DL |
(Showing top 50 of 79 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.